Blink Health LLC, a provider of consumer price discounts for prescription drugs, said it has terminated its relationship with Express Scripts Holding Co., a pharmacy-benefit manager that helped arrange the new price break for Lilly’s insulin.
NYS Entity Status
NYS Filing Date
JANUARY 15, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2014 - JOSEPH CORY HOLDINGS LLC, OF NEW JERSEY
AROUND THE WEB
- Blink Health Ends Pact With Express Scripts for Lilly Insulin Price Discounts
Tuesday Jun 13, 2017
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- 2017 Tournament Of Stars Rosters
By BA Staff - Saturday Jun 24, 2017
- Lincoln-Sudbury Claims State Title to Round Out Final Nike/USL HSB Top 25
By mschneider - Tuesday Jun 20, 2017
- This Morning with Gordon Deal September 19, 2016
By email@example.com (Compass Media Networks) - Monday Sep 19, 2016
Explosions at the New Jersey shore, New York City and a New Jersey train station, Islamic State claims that Minnesota mall attacker was a soldier and the election that forgot the voters.
- Ask the NY Giants: Socks with Sandals?
Tuesday Sep 15, 2015
Professional athletes like members of the New York Giants are the inspiration for the latest (counterintuitive) high-fashion trend: wearing socks with sandals. Photo: Stu Woo/The Wall Street Journal
- Former Christie Allies Found Guilty in 'Bridgegate'
Friday Nov 4, 2016
Bridget Kelly, a former deputy chief of staff to New Jersey Gov. Chris Christie (above, with her lawyer), and Bill Baroni, former deputy executive director of the Port Authority of New York and New Jersey, were found guilty on all counts for their roles in the George Washington Bridge scandal. Photo: AP
- 'NY Times' Finally Joins Snapchat Discover
Monday Apr 24, 2017
Does The New York Times joining Snapchat Discover lend an air of respectability to a new platform, and breathe new life into an aging publisher? That's obviously what the partners are planning -- butonly time will tell.